CN104807923A - Method for detecting vanillylmandelic acid in human urine - Google Patents
Method for detecting vanillylmandelic acid in human urine Download PDFInfo
- Publication number
- CN104807923A CN104807923A CN201410034795.8A CN201410034795A CN104807923A CN 104807923 A CN104807923 A CN 104807923A CN 201410034795 A CN201410034795 A CN 201410034795A CN 104807923 A CN104807923 A CN 104807923A
- Authority
- CN
- China
- Prior art keywords
- vma
- urine
- hplc
- acid
- detect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- CGQCWMIAEPEHNQ-UHFFFAOYSA-N Vanillylmandelic acid Chemical compound COC1=CC(C(O)C(O)=O)=CC=C1O CGQCWMIAEPEHNQ-UHFFFAOYSA-N 0.000 title claims abstract description 92
- 210000002700 urine Anatomy 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims abstract description 22
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 36
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 27
- 238000004128 high performance liquid chromatography Methods 0.000 claims abstract description 21
- 239000000287 crude extract Substances 0.000 claims abstract description 8
- 238000010812 external standard method Methods 0.000 claims abstract description 6
- 238000010521 absorption reaction Methods 0.000 claims abstract description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 239000012074 organic phase Substances 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 238000010828 elution Methods 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- 239000012071 phase Substances 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- 239000012266 salt solution Substances 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 238000012360 testing method Methods 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 2
- 230000008018 melting Effects 0.000 claims description 2
- 238000005260 corrosion Methods 0.000 abstract 1
- 230000007797 corrosion Effects 0.000 abstract 1
- 230000020477 pH reduction Effects 0.000 abstract 1
- 238000001514 detection method Methods 0.000 description 11
- 150000003943 catecholamines Chemical class 0.000 description 7
- JWJCTZKFYGDABJ-UHFFFAOYSA-N Metanephrine Chemical compound CNCC(O)C1=CC=C(O)C(OC)=C1 JWJCTZKFYGDABJ-UHFFFAOYSA-N 0.000 description 4
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- QRMZSPFSDQBLIX-UHFFFAOYSA-N homovanillic acid Chemical compound COC1=CC(CC(O)=O)=CC=C1O QRMZSPFSDQBLIX-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 206010029260 Neuroblastoma Diseases 0.000 description 3
- 208000028591 pheochromocytoma Diseases 0.000 description 3
- 238000008157 ELISA kit Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 238000003859 hyphenated technique Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 201000011519 neuroendocrine tumor Diseases 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- -1 HVA) Chemical compound 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010020802 Hypertensive crisis Diseases 0.000 description 1
- 206010052399 Neuroendocrine tumour Diseases 0.000 description 1
- YNYAYWLBAHXHLL-UHFFFAOYSA-N Normetanephrine Chemical compound COC1=CC(C(O)CN)=CC=C1O YNYAYWLBAHXHLL-UHFFFAOYSA-N 0.000 description 1
- YNYAYWLBAHXHLL-MRVPVSSYSA-N Normetanephrine Natural products COC1=CC([C@H](O)CN)=CC=C1O YNYAYWLBAHXHLL-MRVPVSSYSA-N 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 201000009267 bronchiectasis Diseases 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000007812 electrochemical assay Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000016065 neuroendocrine neoplasm Diseases 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 230000036581 peripheral resistance Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The present invention relates to a method for detecting vanillylmandelic acid in human urine. The method comprises: taking human urine, and carrying out acidification corrosion protection with HCl so as to long-timely store at a temperature of -80 DEG C; extracting the urine with ethyl acetate, volatilizing, dissolving with acetic acid, and carrying out other processes so as to obtain a VMA crude extract; and separating the crude extract through HPLC, obtaining the stable and single VMA absorption peak through a UV detector at a wavelength of 280 nm, drawing a VMA standard curve through an external standard method, and finally calculating the VMA content. The method of the present invention has characteristics of low cost and easy operation, and provides a rapid, inexpensive and sensitive method for detecting VMA in human urine.
Description
Technical field
The present invention relates to medical science, in especially a kind of people's urine, detect the method for vanillylmandelic acid (VMA).
Background technology
Catecholamine is the parahormone secreted by adrenal medella, which includes dopamine, adrenaline and adrenalectomy element.These hormones often because physics or spiritual stress reaction, are released in blood circulation, improve cerebral nerve impulsion and transmit, and release glucose and fatty acid are to provide energy, and bronchiectasis and pupil amplify.Most of catecholamine can be become vanillylmandelic acid (VMA) (Vanilmandelic acid by metabolic degradation, VMA), homovanillic acid (homovanillic acid, HVA), metanephrine (metanephrine) and norepinephrine (normetanephrine), only have a small amount of catecholamine to excrete with urine.
VMA has another name called 3 methoxy 4 hydroxymandelic acid or 4-hydroxy-3-methoxy mandelic acid, is the metabolic product of a kind of catecholamines adrenaline and adrenalectomy element, finally excretes with urine.The content of VMA in urine sample is highly stable, only has content after there is stress reaction just can slightly increase.But neuroblastoma (neuroblastomas), pheochromocytoma (pheochromocytomas) and other neuroendocrine tumor (neuroendocrine tumors) can produce catecholamine in a large number, cause the sharp increase of VMA content.Because a large amount of catecholamine enters blood circulation, make vessel retraction, peripheral resistance increases, and increased heart rate, the hurried rising of paroxysmal appears in blood pressure.The clinical manifestation of these patients is continuation hypertension, palpitaition, n and V, breathe hard, chest constrains, headache, numb, a large amount of perspiration of brothers, eye-blurred etc., the hypertensive crisis such as cerebral hemorrhage or pulmonary edema may be there is in severe patient.Urine VMA too high levels is an important symbol of Secretion of Catecholamine exception, is the first-selected mark of diagnosis of neuroblastoma and pheochromocytoma.
The detection gimmick of current VMA mainly contains colorimetric-hyphenated techniques chromatography, ELISA and HPLC method.
Commercially available VMA detects ELISA kit and generally applies double-antibody sandwich enzyme-labeled immunity assay VMA level.ELISA kit has sensitive, quick feature, but shortcoming to be stability not high, the technology of operating personnel is had higher requirements.And this series products is mainly external import, as Cloud-Clone Corp. (U.S.), Biocompare (U.S.), RDG (U.S.), Eaglebio (U.S.) etc., expensive.Because the core technologies such as antibody are external monopolization, domesticly there is no independent research product, fundamentally cannot reduce reagent cost.
Colorimetric-hyphenated techniques chromatography, the detection kit of current domestic approval is the vanillylmandelic acid (VMA) assay kit (state's food medicine prison No. 2402315th, tool (entering) word 2010) that Spain Biosystems S.A. produces, the method adopts anion exchange resins to be kept on resin by the VMA absorption in urine, other interfering materials then can not be retained and clear, last eluting VMA.The oxidized formation vanilla of VMA is plain in the basic conditions again, carries out quantitative test by ultraviolet spectrometry colourimetry.The method efficiency is high, detect property good, shortcoming be this kit for monopolize product abroad, expensive.
HPLC technology for detection VMA is considered to the most promising VMA detection method.Wherein the research of electrochemical assay is quite ripe, modifies method (Taran), hydrolysis and condensation (Fa μ ler, Lionetto) and capillary electrophoresis technique detection method and also set up one after another after this outer chemical.These method advantages are that highly sensitive, detection speed is fast, but need specific apparatus, and expensive, cost is high, and operating personnel need special training, are difficult to be widely used in clinical.HPLC combined U V detection method rarely has report, and UV detecting device cost is low, all can be equipped with UV detecting device while generally purchasing HPLC.
Summary of the invention
The present invention will solve the shortcoming of above-mentioned prior art, detects the method for vanillylmandelic acid (VMA) in providing a kind of quick, efficient, cheap people to urinate.
The present invention solves the technical scheme that its technical matters adopts: the method detecting vanillylmandelic acid (VMA) in this people's urine, and its step comprises:
1) get human urine HCl acidifying, preserve under-80 DEG C of conditions, urine is extracted with ethyl acetate after melting, volatilizees, and acetic acid dissolves again, can obtain VMA crude extract;
2) above-mentioned crude extract is separated through HPLC, under UV detecting device 280nm wavelength, obtains and stablizes single VMA absorption peak, and draw VMA typical curve by external standard method, finally calculate the content of VMA.
As preferably, wherein step 1) specific as follows:
A) after collecting freshly voided urine, add 5M HCl acidifying, put into-80 DEG C of refrigerators and preserve, until start subsequent experimental;
B) after urine is melted, get 4ml urine and be preinstalled with in the 15ml centrifuge tube of 2g NaCl to one, the mixing 10min that turns upside down forms saturated salt solution;
C) add 4ml ethyl acetate, turn upside down mixing 5min; The centrifugal 5min of 4000g, careful upper organic phase of drawing is in a new 50ml round bottom centrifuge tube;
D) repeat b-c and walk 2 times, obtain upper organic phase 12ml altogether;
E) centrifuge tube metal heater is heated to 45 DEG C, high wind volatilization in vent cabinet, until all ethyl acetate volatilizations completely, obtains yellow or black precipitate;
F) add 400 μ l1% acetums, fully shake, 4 DEG C of dissolvings of spending the night;
G) 15000g centrifugal after, moved on to by supernatant in new 1.5ml centrifuge tube, 4 DEG C of preservations are no more than 1 week, wait for HPLC detect.
As preferably, wherein HPLC condition is:
Pillar: SP-C18 (4.6mm*250mm, 5um);
Mobile phase: A (water: acetic acid=98: 1): B (water: methyl alcohol: acetic acid=68: 30: 2) gradient elution;
Gradient: 0-15min:100%A-20%A
15-20min：20％A
20-21min：20％A-100％A
21-35min：100％A
Flow velocity: 0.8ml/min;
Determined wavelength: UV280nm;
Applied sample amount: 100 μ l.
As preferably, external standard method drafting VMA typical curve step is as follows: take VMA with electronic analytical balance, acetic acid with 1% is configured to the VMA solution of concentration gradient of 1ng/ μ l, 2.5ng/ μ l, 5ng/ μ l, 10ng/ μ l, 20ng/ μ l, 100ng/ μ l, the VMA solution of these concentration gradients successively upper HPLC column is detected, and according to its testing result drawing standard curve.
Inventing useful effect is: cost of the present invention is low, easy and simple to handle, provides the method detecting VMA in a kind of quick, cheap, sensitive people urine.
Accompanying drawing explanation
Fig. 1 is the HPLC peak figure after the VMA loading of 20ng/ μ l;
Fig. 2 is VMA canonical plotting;
Fig. 3 is the VMA detection figure in embodiment 1;
Fig. 4 is the VMA detection figure in embodiment 2;
Embodiment
Below in conjunction with accompanying drawing, the invention will be further described:
With reference to accompanying drawing:
The detection method that this people of the present invention urinates VMA comprises the following steps:
1) preparation of VMA crude extract
A) after collecting freshly voided urine, add 5M HCl acidifying, put into-80 DEG C of refrigerators and preserve, until start subsequent experimental;
B) after urine is melted, get 4ml urine and be preinstalled with in the 15ml centrifuge tube of 2g NaCl to one, the mixing 10min that turns upside down forms saturated salt solution;
C) add 4ml ethyl acetate, turn upside down mixing 5min; The centrifugal 5min of 4000g, careful upper organic phase of drawing is in a new 50ml round bottom centrifuge tube;
D) repeat b-c and walk 2 times, obtain upper organic phase 12ml altogether;
E) centrifuge tube metal heater is heated to 45 DEG C, high wind volatilization in vent cabinet, until all ethyl acetate volatilizations completely, obtains yellow or black precipitate;
F) add 400 μ l1% acetums, fully shake, 4 DEG C of dissolvings of spending the night;
G) 15000g centrifugal after, moved on to by supernatant in new 1.5ml centrifuge tube, 4 DEG C of preservations are no more than 1 week, wait for HPLC detect.
2) above-mentioned crude extract is separated through HPLC, under UV detecting device 280nm wavelength, obtains and stablizes single VMA absorption peak, and draw VMA typical curve by external standard method, finally calculate the content of VMA.
Wherein HPLC condition is:
Pillar: SP-C18 (4.6mm*250mm, 5um);
Mobile phase: A (water: acetic acid=98: 1): B (water: methyl alcohol: acetic acid=68: 30: 2) gradient elution;
Gradient: 0-15min:100%A-20%A
15-20min：20％A
20-21min：20％A-100％A
21-35min：100％A
Flow velocity: 0.8ml/min;
Determined wavelength: UV280nm;
Applied sample amount: 100 μ l.
VMA Specification Curve of Increasing method: take VMA (Sigma with electronic analytical balance, H0131), acetic acid with 1% is configured to the VMA solution of concentration gradient of 1ng/ μ l, 2.5ng/ μ l, 5ng/ μ l, 10ng/ μ l, 20ng/ μ l, 100ng/ μ l, is detected by the VMA solution of these concentration gradients successively upper HPLC column.
HPLC peak figure after the VMA loading of 20ng/ μ l as shown in Figure 1.VMA peak appears at 11.0-11.5min.
The testing result of variable concentrations VMA is as follows:
| VMA(μg) | Peak area |
| 10 | 8823731 |
| 2 | 1630482 |
| 1 | 792206 |
| 0.5 | 146109 |
| 0.25 | 146109 |
| 0.1 | 60764 |
Drawing standard curve as shown in Figure 2.
The content that can calculate VMA according to peak area is:
VMA content (μ g)=(peak area+132119)/894737
Calculate that the content of VMA in urine is according to the content of VMA in upper sample:
VMA concentration (μ g/ml)=VMA content * 4/4 in people's urine.
The detection case of VMA in people's urine
Embodiment 1:VMA detects figure as shown in Figure 3.
| Ret.Time | Conc. | Area | Height |
| 11.429 | 1.14448 | 238426 | 17914 |
The content calculated containing VMA in the every 100 μ l of sample on HPLC is 0.414 μ g.
Calculating VMA content in urine is 0.414 μ g/ml.
Embodiment 2:VMA detects figure as shown in Figure 4:
| Ret.Time | Conc. | Area | Height |
| 11.414 | 2.15421 | 458154 | 32338 |
The content calculated containing VMA in the every 100 μ l of sample on HPLC is 0.659 μ g.
Calculating VMA content in urine is 0.659 μ g/ml.
In addition to the implementation, the present invention can also have other embodiments.All employings are equal to the technical scheme of replacement or equivalent transformation formation, all drop on the protection domain of application claims.
Claims (4)
1. detect a method for vanillylmandelic acid (VMA) in people's urine, its step comprises:
1) get human urine HCl acidifying, preserve under-80 DEG C of conditions, urine is extracted with ethyl acetate after melting, volatilizees, and acetic acid dissolves again, can obtain VMA crude extract;
2) above-mentioned crude extract is separated through HPLC, under UV detecting device 280nm wavelength, obtains and stablizes single VMA absorption peak, and draw VMA typical curve by external standard method, finally calculate the content of VMA.
2. detect the method for vanillylmandelic acid (VMA) in people's urine according to claim 1, it is characterized in that: step 1) specific as follows:
A) after collecting freshly voided urine, add 5M HCl acidifying, put into-80 DEG C of refrigerators and preserve, until start subsequent experimental;
B) after urine is melted, get 4ml urine and be preinstalled with in the 15ml centrifuge tube of 2g NaCl to one, the mixing 10min that turns upside down forms saturated salt solution;
C) add 4ml ethyl acetate, turn upside down mixing 5min; The centrifugal 5min of 4000g, careful upper organic phase of drawing is in a new 50ml round bottom centrifuge tube;
D) repeat b-c and walk 2 times, obtain upper organic phase 12ml altogether;
E) centrifuge tube metal heater is heated to 45 DEG C, high wind volatilization in vent cabinet, until all ethyl acetate volatilizations completely, obtains yellow or black precipitate;
F) add 400 μ l1% acetums, fully shake, 4 DEG C of dissolvings of spending the night;
G) 15000g centrifugal after, moved on to by supernatant in new 1.5ml centrifuge tube, 4 DEG C of preservations are no more than 1 week, wait for HPLC detect.
3. detect the method for vanillylmandelic acid (VMA) in people's urine according to claim 1, it is characterized in that: HPLC condition is:
Pillar: SP-C18 (4.6mm*250mm, 5um);
Mobile phase: A (water: acetic acid=98: 1): B (water: methyl alcohol: acetic acid=68: 30: 2) gradient elution;
Gradient: 0-15min:100%A-20%A
15-20min：20％A
20-21min：20％A-100％A
21-35min：100％A
Flow velocity: 0.8ml/min;
Determined wavelength: UV280nm;
Applied sample amount: 100 μ l.
4. in people's urine according to claim 1, detect the method for vanillylmandelic acid (VMA), it is characterized in that: external standard method drafting VMA typical curve step is as follows: take VMA with electronic analytical balance, acetic acid with 1% is configured to the VMA solution of concentration gradient of 1ng/ μ l, 2.5ng/ μ l, 5ng/ μ l, 10ng/ μ l, 20ng/ μ l, 100ng/ μ l, the VMA solution of these concentration gradients successively upper HPLC column is detected, and according to its testing result drawing standard curve.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410034795.8A CN104807923A (en) | 2014-01-23 | 2014-01-23 | Method for detecting vanillylmandelic acid in human urine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410034795.8A CN104807923A (en) | 2014-01-23 | 2014-01-23 | Method for detecting vanillylmandelic acid in human urine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104807923A true CN104807923A (en) | 2015-07-29 |
Family
ID=53692931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410034795.8A Pending CN104807923A (en) | 2014-01-23 | 2014-01-23 | Method for detecting vanillylmandelic acid in human urine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104807923A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105175530A (en) * | 2015-08-14 | 2015-12-23 | 苏州博源医疗科技有限公司 | Vanilmandelic acid immune detection reagent and preparation method thereof |
| CN106442784A (en) * | 2016-09-23 | 2017-02-22 | 瀚盟测试科技（天津）有限公司 | UPLC-MS/MS (ultra performance liquid chromatography-tandem mass spectrometry) detection method for concentrations of hippuric acid, methyl hippuric acid and asaronic acid in human urine |
| CN106610405A (en) * | 2016-12-05 | 2017-05-03 | 江苏省人民医院 | Method for detecting contents of catecholamine substances and methoxy metabolites in human urine |
| CN109142594A (en) * | 2018-08-14 | 2019-01-04 | 美康生物科技股份有限公司 | Mass spectrometry kit for catecholamine and metanephrine in Accurate Determining body fluid sample |
| CN111103384A (en) * | 2019-12-25 | 2020-05-05 | 南京希麦迪医药科技有限公司 | Method for measuring concentration of endogenous homovanillic acid and vanillic mandelic acid in human urine by liquid chromatography-mass spectrometry |
| CN112946150A (en) * | 2019-11-26 | 2021-06-11 | 深圳华大临床检验中心 | Method and kit for rapidly detecting vanillic acid, vanillylmandelic acid, 5-hydroxyindoleacetic acid and creatinine in human urine |
| CN113024374A (en) * | 2021-03-12 | 2021-06-25 | 杭州度安医学检验实验室有限公司 | Kit and method for simultaneously extracting organic acid and amino acid |
| CN116298015A (en) * | 2023-03-21 | 2023-06-23 | 北京豪思生物科技股份有限公司 | Detection method of vanilla mandelic acid and homovanillic acid in urine and application thereof |
-
2014
- 2014-01-23 CN CN201410034795.8A patent/CN104807923A/en active Pending
Non-Patent Citations (4)
| Title |
|---|
| J.P.M. WIELDERS等: "Analysis of vanillylmandelic acid, homovanillic acid and 5-hydroxyindoleacetic acid in human urine by high-performance liquid chromatography andfluorometry", 《JOURNAL OF CHROMATOGRAPHY》 * |
| LAURA M. BERTANI-DZIEDZIC 等: "ROUTINE REVERSED-PHASE HIGH-PERFORMANCE LIQUID ROUTINE REVERSED-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC MEASUREMENT OF URINARY VANILLYLMANDELIC ACID IN PATIENTS WITH NEURAL CREST TUMORS", 《JOURNAL OF CHROMATOGRAPHY》 * |
| 曾立明等: "高效液相色谱测定尿中香草扁桃酸含量", 《湖南医科大学学报》 * |
| 胡云良等: "反相高效液相色谱法测定尿液香草扁桃酸的含量", 《浙江医学》 * |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105175530A (en) * | 2015-08-14 | 2015-12-23 | 苏州博源医疗科技有限公司 | Vanilmandelic acid immune detection reagent and preparation method thereof |
| CN106442784A (en) * | 2016-09-23 | 2017-02-22 | 瀚盟测试科技（天津）有限公司 | UPLC-MS/MS (ultra performance liquid chromatography-tandem mass spectrometry) detection method for concentrations of hippuric acid, methyl hippuric acid and asaronic acid in human urine |
| CN106442784B (en) * | 2016-09-23 | 2019-01-04 | 瀚盟测试科技（天津）有限公司 | The UPLC-MS/MS detection method of hippuric acid, toluric acid and almond acid concentration in human urine |
| CN106610405A (en) * | 2016-12-05 | 2017-05-03 | 江苏省人民医院 | Method for detecting contents of catecholamine substances and methoxy metabolites in human urine |
| CN109142594A (en) * | 2018-08-14 | 2019-01-04 | 美康生物科技股份有限公司 | Mass spectrometry kit for catecholamine and metanephrine in Accurate Determining body fluid sample |
| CN112946150A (en) * | 2019-11-26 | 2021-06-11 | 深圳华大临床检验中心 | Method and kit for rapidly detecting vanillic acid, vanillylmandelic acid, 5-hydroxyindoleacetic acid and creatinine in human urine |
| CN111103384A (en) * | 2019-12-25 | 2020-05-05 | 南京希麦迪医药科技有限公司 | Method for measuring concentration of endogenous homovanillic acid and vanillic mandelic acid in human urine by liquid chromatography-mass spectrometry |
| CN113024374A (en) * | 2021-03-12 | 2021-06-25 | 杭州度安医学检验实验室有限公司 | Kit and method for simultaneously extracting organic acid and amino acid |
| CN113024374B (en) * | 2021-03-12 | 2022-07-05 | 杭州度安医学检验实验室有限公司 | Kit and method for simultaneously extracting organic acid and amino acid |
| CN116298015A (en) * | 2023-03-21 | 2023-06-23 | 北京豪思生物科技股份有限公司 | Detection method of vanilla mandelic acid and homovanillic acid in urine and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104807923A (en) | Method for detecting vanillylmandelic acid in human urine | |
| CN110045040A (en) | A method of measurement intestinal contents or excrement Short-Chain Fatty Acids content | |
| CN102288720A (en) | Method for detecting benzo(a)pyrene of oiltea camellia seed oil | |
| Ivanescu et al. | Artemisinin evaluation in Romanian Artemisia annua wild plants using a new HPLC/MS method | |
| CN101692073A (en) | Method for measuring antibiotic in animal excretion | |
| Dadfarnia et al. | Indirect Determination of Sulfadiazine by Cloud Point Extraction/Flow Injection‐Flame Atomic Absorption (CPE/FI‐FAAS) Spectrometry | |
| CN108610258B (en) | A new phenolic compound and its preparation method and medicinal use | |
| CN105606556B (en) | The ultraviolet spectrophotometry of polyoses content in fokien angiopteris rhizome medicinal material | |
| CN101581707B (en) | A method for simultaneous detection of acetoin and ligustrazine in vinegar | |
| CN104965032A (en) | Method of measuring content of ginsenoside in American ginseng | |
| CN101339137B (en) | Method for determining saponin content of SmilaxscobinicaulisC.H.Wringh or its formulation | |
| Rawat et al. | Quantification of protodioscin and prototribestin in fruits of Tribulus terrestris L. collected from different phyto-geographical zones of India | |
| CN104122361A (en) | Method for analyzing daytime severe cold and flu capsules by high performance liquid chromatography | |
| CN103565781A (en) | Composite, preparation thereof and application of composite in preparing antidepressant drug | |
| CN103983735B (en) | A kind of detection method preparing medical capsule for treating pelvic inflammatory disease | |
| CN101726551A (en) | Method for extracting and detecting hydrocortisone in hairs | |
| CN106501333B (en) | A kind of preparation and its application of the sensor for the detection of vanillyl mandelic acid | |
| CN101181343A (en) | Mass control method of rhinitis tablet of climbing groundsel and spikemoss | |
| CN101810752B (en) | Method for detecting quality of Chinese medicament for treating prostatitis | |
| CN101224266A (en) | Quality controlling method of HuoXiangZhengQi soft capsule | |
| CN101091743A (en) | Extractive of red sage root of Chinese traditional medicine, and preparation method | |
| CN106770710B (en) | A kind of method of turmeric cellulose content in measurement fish meal | |
| CN102370691A (en) | Ibufenac traditional Chinese preparation detection method | |
| Wu et al. | Fatty Alcohol-Assisted Electro-Driven Liquid Membrane Multi-Stage Extraction Technology for Selective Separation and Purification of 3, 4-Dihydroxybenzaldehyde from Salvia miltiorrhiza Bge. | |
| CN104535382A (en) | Pretreatment method for measuring lead in blood by graphite furnace atomic absorption process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150729 |
|
| WD01 | Invention patent application deemed withdrawn after publication |